Nuclear Medicine/Radiopharmaceuticals Market Size, Share, Trends, Growth and Forecast 2032

Nuclear Medicine/Radiopharmaceuticals Market

Nuclear Medicine/Radiopharmaceuticals Market by Type (Therapeutic and Diagnostic), Procedures (Cardiovascular, Oncology, Central Nervous System, Skeletal, Endocrine, Gastrointestinal, Pulmonary, and Others), Application (Cardiology, Oncology, Thyroid, Neurology, and Others), and End User (Research Institutes, Hospitals, Diagnostic Centers, and Others), and By Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032

Category: Healthcare Report Format : PDF Pages: 201 Report Code: ZMR-4797 Published Date: Aug-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 5.59 Billion USD 11.46 Billion 8.3% 2023

Nuclear Medicine/Radiopharmaceuticals Market

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Nuclear Medicine/ Radiopharmaceuticals Market, 2016-2025 (USD Million)
    • 2.2. Nuclear Medicine/ Radiopharmaceuticals Market: Snapshot
  • Chapter 3. Nuclear Medicine/ Radiopharmaceuticals Market - Industry Analysis
    • 3.1. Nuclear Medicine/ Radiopharmaceuticals Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Application
      • 3.6.2. Market attractiveness analysis by Region
  • Chapter 4. Nuclear Medicine/ Radiopharmaceuticals Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Nuclear Medicine/ Radiopharmaceuticals Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Application launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Nuclear Medicine/ Radiopharmaceuticals Market -Application Analysis
    • 5.1. Global Nuclear Medicine/ Radiopharmaceuticals Market overview: By Application type
      • 5.1.1. Global Nuclear Medicine/ Radiopharmaceuticals Market share, By Application,2018 and 2025
    • 5.2. Diagnostics
      • 5.2.1. Global Nuclear Medicine/ Radiopharmaceuticals Market by Diagnostics, 2016-2025 (USD Million)
    • 5.3. Genetic Relatedness
      • 5.3.1. Global Nuclear Medicine/ Radiopharmaceuticals Market by Genetic Relatedness, 2016-2025 (USD Million)
    • 5.4. Nutrition, Wellness, & Lifestyle
      • 5.4.1. Global Nuclear Medicine/ Radiopharmaceuticals Market by Nutrition, Wellness, & Lifestyle, 2016-2025 (USD Million)
    • 5.5. Reproductive Health
      • 5.5.1. Global Nuclear Medicine/ Radiopharmaceuticals Market by Reproductive Health, 2016-2025 (USD Million)
    • 5.6. Sports Nutrition & Health
      • 5.6.1. Global Nuclear Medicine/ Radiopharmaceuticals Market by Sports Nutrition & Health, 2016-2025 (USD Million)
    • 5.7. Pharmacogenetic Testing
      • 5.7.1. Global Nuclear Medicine/ Radiopharmaceuticals Market by Pharmacogenetic Testing, 2016-2025 (USD Million)
    • 5.8. Personalized Medicine
      • 5.8.1. Global Nuclear Medicine/ Radiopharmaceuticals Market by Personalized Medicine, 2016-2025 (USD Million)
    • 5.9. Others
      • 5.9.1. Global Nuclear Medicine/ Radiopharmaceuticals Market by others, 2016-2025 (USD Million)
  • Chapter 6. Global Nuclear Medicine/ Radiopharmaceuticals Market - Regional Analysis
    • 6.1. Global Nuclear Medicine/ Radiopharmaceuticals Market overview: by Region
      • 6.1.1. Global Nuclear Medicine/ Radiopharmaceuticals Marketshare, by Region, 2018 and 2025
    • 6.2. North America
      • 6.2.1. North America Nuclear Medicine/ Radiopharmaceuticals Market, 2016-2025 (USD Million)
      • 6.2.2. North America Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.2.3. The U.S.
        • 6.2.3.1. The U.S.Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.2.4. Rest of North America
        • 6.2.4.1. Rest of North America Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
    • 6.3. Europe
      • 6.3.1. Europe Nuclear Medicine/ Radiopharmaceuticals Market, 2016-2025 (USD Million)
      • 6.3.2. Europe Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.3.3. UK
        • 6.3.3.1. U.K.Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.3.4. France
        • 6.3.4.1. France Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.3.5. Germany
        • 6.3.5.1. Germany Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.3.6. Rest of Europe
        • 6.3.6.1. Rest of EuropeNuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market, 2016-2025 (USD Million)
      • 6.4.2. Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.4.3. China
        • 6.4.3.1. China Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.4.4. Japan
        • 6.4.4.1. Japan Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.4.5. India
        • 6.4.5.1. India Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.4.6. Rest of Asia Pacific
        • 6.4.6.1. Rest of Asia Pacific Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
    • 6.5. Latin America
      • 6.5.1. Latin America Nuclear Medicine/ Radiopharmaceuticals Market, 2016-2025 (USD Million)
      • 6.5.2. Latin America Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.5.3. Brazil
        • 6.5.3.1. Brazil Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
      • 6.5.4. Rest of LatinAmerica
        • 6.5.4.1. Rest of LatinAmerica Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
    • 6.6. The Middle East and Africa
      • 6.6.1. The Middle East and Africa Nuclear Medicine/ Radiopharmaceuticals Market, 2016-2025 (USD Million)
      • 6.6.2. The Middle East and Africa Nuclear Medicine/ Radiopharmaceuticals Market revenue, By Application,2016-2025 (USD Million)
  • Chapter 7. Company Profiles
    • 7.1. 23andMe, Inc.
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Application Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Ancestry
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Application Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Xcode Life
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Application Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Developments
    • 7.4. Helix OpCo LLC
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Application Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Developments
    • 7.5. Diagnomics, Inc
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Application Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Gene By Gene, Ltd.
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Application Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Positive Biosciences, Ltd.
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Application Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. Color Genomics
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Application Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Futura Genetics
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Application Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Pathway Genomics
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Application Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development

Methodology

FrequentlyAsked Questions

Nuclear medicine/ radiopharmaceuticals market was valued at approximately USD 5.82 Billion in 2018, and is expected to generate revenue of around USD 14.11 Billion by end of 2025

The report also includes detailed profiles of key players such as GE Healthcare, Curium, Cardinal Health, Bayer, Advanced Accelerator Applications, Lantheus Medical Imaging, and Jubilant Life Sciences among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed